Eledon Pharmaceuticals, Inc. (NasdaqCM: ELDN)
Health Care · Biotechnology · US
$2.48
-0.40% today · -8.8% 1Y
Eledon Pharmaceuticals, Inc. (NasdaqCM: ELDN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $201.73M and employs 33 people.
Over the last twelve months the share price has lost 8.8%, trading between 1.35 and 4.60.
Tweenvest scores Eledon Pharmaceuticals, Inc. across four factors: quality 46/100, value 51/100. Its strongest factor is value.
ELDN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $201.73M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.99
- Dividend yield
- —
- Beta (5Y)
- 0.85
- 52-week high
- $4.60
- 52-week low
- $1.35
- Avg volume (3M)
- —
- Shares outstanding
- 81.34M
- Employees
- 33
- Next earnings
- —
About Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.
- ISIN
- US28617K1016
- Listed since
- Sep 17, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Exagen Inc.NasdaqGM: XGN | $203.98M | $8.42 | +3.06% |
| Japan Tissue Engineering Co., Ltd.TSE: 7774 | $203.38M | ¥793.00 | -4.80% |
| SinoMab BioScience LimitedSEHK: 3681 | $203.20M | HK$1.15 | +13.86% |
| Compugen Ltd.NasdaqCM: CGEN | $201.76M | $2.11 | -0.94% |
| Biomm S.A.BOVESPA: BIOM3 | $201.65M | R$7.34 | +13.80% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $200.93M | $27.30 | -1.30% |
| Whitehawk Therapeutics, Inc.NasdaqCM: WHWK | $200.67M | $3.52 | -4.86% |
| S.Biomedics Co., Ltd.KOSDAQ: A304360 | $200.37M | ₩21,750.00 | +4.07% |
Figures last refreshed Oct 11, 2026.